TITLE
(PROF/DR/): DR.
NAME: OLUWADAMILOLA
OMOLARA OJO
POSITION:
ASSOCIATE PROFESSOR SPECIALISATION:
NEUROLOGY
EDUCATION/TRAINING (Begin with Bachelor’s degree or other initial professional education,
such as nursing, include postdoctoral training and residency training if
applicable. Add/delete rows as necessary.)
|
INSTITUTION AND LOCATION |
DEGREE (if
|
Completion Date MM/YYYY
|
FIELD OF STUDY
|
|
University of Ilorin, |
MBBS |
01/1997 |
Medicine & Surgery |
|
Residency |
MWACP |
04/2004 |
Internal Medicine |
|
Residency in |
FMCP |
05/2007 |
Neurology |
|
Clinical Research Fellowship Program in Clinical National Postgraduate |
MD |
02/2015
08/2019
06/2023 |
Movement Disorders
Clinical epidemiology & biostatistics Medicine |
|
|
|
|
|
NAME: OLUWADAMILOLA
OMOLARA OJO
POSITION:
ASSOCIATE PROFESSOR SPECIALISATION:
NEUROLOGY
EDUCATION/TRAINING (Begin with Bachelor’s degree or other initial professional education,
such as nursing, include postdoctoral training and residency training if
applicable. Add/delete rows as necessary.)
|
INSTITUTION AND LOCATION |
DEGREE (if
applicable)
|
Completion Date MM/YYYY
|
FIELD OF STUDY
|
|
University of Ilorin,
Nigeria |
MBBS |
01/1997 |
Medicine & Surgery |
|
Residency
in Internal Medicine, University of Ilorin Teaching Hospital (National
Postgraduate Medical College of Nigeria & West African College of
Physicians) |
MWACP |
04/2004 |
Internal Medicine |
|
Residency in
Neurology, Lagos University Teaching Hospital & University of Ilorin
Teaching Hospital (National Postgraduate Medical College of Nigeria) |
FMCP |
05/2007 |
Neurology |
|
Clinical Research Fellowship
Movement Disorders, Center For Neurologic Restoration, Cleveland Clinic, OH,
USA Program in Clinical
Effectiveness, Harvard T.H. Chan School of Public Health, Boston, MA, USA National Postgraduate
Medical College of Nigeria, Lagos, Nigeria |
MD |
02/2015
08/2019
06/2023 |
Movement Disorders
Clinical epidemiology & biostatistics Medicine |
|
|
|
|
|
A. Personal
Statement
As a mid-career neurologist, I have cultivated a passion
for bridging the gaps in knowledge regarding clinical and pathogenetic
mechanisms of non-communicable diseases in Nigeria, specifically the
neurodegenerative disorders through engaging in internationally visible
research and collaborations. I am an academic researcher and clinical
neurologist with insights into the acute need to bolster neurosciences
education (basic and clinical) within Nigeria and Africa. I am committed towards
empowering younger physicians with knowledge in the clinical neurosciences, not
only to improve early recognition, diagnosis, care/management and above all,
prevention of these diseases in our setting, but also to inspire interest, and
mentor the next generation of neuroscientists. My research interests focus on
the clinical profile and genetics of Parkinson disease, other movement
disorders and neurodegenerative dementias in Nigerians and black Africans. Ultimately,
through national, regional and international collaborations, the goal is for research
output to translate into sustainable policies that improve neurology education,
facilitate research in basic and clinical neurosciences, and advances access of
persons with movement disorders to care.
B. Positions,
Scientific Appointments, and Honours
● Treasurer-elect,
International Parkinson’s disease and Movement Disorders Society-African
section, 2023- 2025
● International
Parkinson and Movement Disorder Society (MDS) LEAP Class of 2019 (African
section representative)
●
American Academy of Neurology International Scholarship
Award, 2011
●
Member, Editorial Board, Brain and Behaviour, Wiley.
●
Associate Professor, Department of Medicine, University
of Lagos, October 2020 –
●
Senior Lecturer, Department of Medicine, University of
Lagos, October 2015 – September 2020
●
Honorary Consultant Neurologist, Lagos University
Teaching Hospital, May 2013 – till date
●
Lecturer I, Department of Medicine, University of
Lagos, September 2011 – September 2015
C. Selected
Most Recent Publications /Contributions
to Knowledge (five (5) maximum)
- Saylor D, Rijke N,
McDonell J, et al. (2025). Recommendations for essential medicines for
multiple sclerosis in low-resource settings. Multiple Sclerosis (Houndmills,
Basingstoke, England) 31(4) 464-473. doi:10.1177/13524585241308134.
- Ojo OO, Bandres-Ciga S,
Makarious MB, et al. (2024). GBA1 rs3115534 Is Associated with REM Sleep
Behavior Disorder in Parkinson’s Disease in Nigerians. Movement Disorders.39(4):728-733.
doi:10.1002/mds.29753
- Ojo, OO, Agabi OP, Ishola,
IO, et al (2024). A protocol for the study of environmental risk factors
and candidate gene– environment interactions in neurodegenerative
disorders in Nigeria (SERGEND): A cross-sectional descriptive study. Journal
of Clinical Sciences 21(2):p 49-56. doi:10.4103/jcls.jcls_7_24
- Rizig M, Bandres-Ciga S,
Makarious MB, et al (2023). Identification of genetic risk loci and causal
insights associated with Parkinson’s disease in African and African
admixed populations: a genome-wide association study. Lancet Neurology
22(11):1015-1025. doi:10.1016/S1474-4422(23)00283-1
- Okunoye O, Ojo OO, Abiodun
O, et al. (2023). MAPT allele and haplotype frequencies in Nigerian
Africans: Population distribution and association with Parkinson’s disease
risk and age at onset. Parkinsonism and Related Disorders.
113:105517. doi:10.1016/j.parkreldis.2023.105517
D. Collaborators/ Networks
(International inclusive, five (5) maximum)
i.
Prof. Njideka U. Okubadejo/ The Nigerian Parkinson’s
Disease Research network
ii.
The Global Parkinson’s Genetics Program (GP2)
iii. Parkinson’s Progression Markers Initiative (PPMI)
iv. The International Parkinson’s Disease Genomics Consortium (IPDGC) and IPDGC Africa
v.
Transforming Parkinson’s Care in Africa (TraPCAf)